Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07592572 · ClinicalTrials.gov registry record · Phase 1
A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants
A Phase 1 study, sponsored by Eli Lilly and Company.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT07592572 is a Phase 1 study that is actively recruiting participants, run by Eli Lilly and Company. The registered enrollment target is 14 participants.
The verdict
NCT07592572, a Phase 1 study, is actively recruiting participants, sponsored by Eli Lilly and Company.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of the study is to see how itraconazole affects LY4395089 in healthy participants. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. There will be fifteen inpatient stays at the clinical research unit (CRU). The study will last about 2 weeks.
Interventions
- DRUG Itraconazole
- DRUG LY4395089
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2026-05-20 |
| Est. Completion | 2026-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07592572
The ClinicalTrials.gov registry entry for NCT07592572 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Itraconazole is the first listed.
NCT07592572 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07592572 about?
NCT07592572 is a clinical study titled "A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants". The purpose of the study is to see how itraconazole affects LY4395089 in healthy participants. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. There will be fifteen inpatient stays at the clinical research unit (CRU). The s...
What is the current status of trial NCT07592572?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2026-05-20. Estimated completion is 2026-07.
What interventions are being tested in trial NCT07592572?
The interventions under investigation include: Itraconazole (DRUG), LY4395089 (DRUG).
Who is sponsoring clinical trial NCT07592572?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.